Form 8-K - Current report:
SEC Accession No. 0001827506-24-000108
Filing Date
2024-12-10
Accepted
2024-12-10 16:08:18
Documents
56
Period of Report
2024-12-10
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K trml-20241210.htm   iXBRL 8-K 28659
2 EX-99.1 tourmalinecorporateoverv.htm EX-99.1 59418
6 tourmalinecorporateoverv001.jpg GRAPHIC 41553
7 tourmalinecorporateoverv002.jpg GRAPHIC 280999
8 tourmalinecorporateoverv003.jpg GRAPHIC 88016
9 tourmalinecorporateoverv004.jpg GRAPHIC 123625
10 tourmalinecorporateoverv005.jpg GRAPHIC 140200
11 tourmalinecorporateoverv006.jpg GRAPHIC 150838
12 tourmalinecorporateoverv007.jpg GRAPHIC 124618
13 tourmalinecorporateoverv008.jpg GRAPHIC 104837
14 tourmalinecorporateoverv009.jpg GRAPHIC 31124
15 tourmalinecorporateoverv010.jpg GRAPHIC 127610
16 tourmalinecorporateoverv011.jpg GRAPHIC 141616
17 tourmalinecorporateoverv012.jpg GRAPHIC 96730
18 tourmalinecorporateoverv013.jpg GRAPHIC 177312
19 tourmalinecorporateoverv014.jpg GRAPHIC 148085
20 tourmalinecorporateoverv015.jpg GRAPHIC 136237
21 tourmalinecorporateoverv016.jpg GRAPHIC 148678
22 tourmalinecorporateoverv017.jpg GRAPHIC 116280
23 tourmalinecorporateoverv018.jpg GRAPHIC 179674
24 tourmalinecorporateoverv019.jpg GRAPHIC 152569
25 tourmalinecorporateoverv020.jpg GRAPHIC 136035
26 tourmalinecorporateoverv021.jpg GRAPHIC 114571
27 tourmalinecorporateoverv022.jpg GRAPHIC 154593
28 tourmalinecorporateoverv023.jpg GRAPHIC 120052
29 tourmalinecorporateoverv024.jpg GRAPHIC 141510
30 tourmalinecorporateoverv025.jpg GRAPHIC 136391
31 tourmalinecorporateoverv026.jpg GRAPHIC 121535
32 tourmalinecorporateoverv027.jpg GRAPHIC 138624
33 tourmalinecorporateoverv028.jpg GRAPHIC 136034
34 tourmalinecorporateoverv029.jpg GRAPHIC 150754
35 tourmalinecorporateoverv030.jpg GRAPHIC 162689
36 tourmalinecorporateoverv031.jpg GRAPHIC 145410
37 tourmalinecorporateoverv032.jpg GRAPHIC 26803
38 tourmalinecorporateoverv033.jpg GRAPHIC 175291
39 tourmalinecorporateoverv034.jpg GRAPHIC 154253
40 tourmalinecorporateoverv035.jpg GRAPHIC 128983
41 tourmalinecorporateoverv036.jpg GRAPHIC 135208
42 tourmalinecorporateoverv037.jpg GRAPHIC 201619
43 tourmalinecorporateoverv038.jpg GRAPHIC 158694
44 tourmalinecorporateoverv039.jpg GRAPHIC 130912
45 tourmalinecorporateoverv040.jpg GRAPHIC 136709
46 tourmalinecorporateoverv041.jpg GRAPHIC 76940
47 tourmalinecorporateoverv042.jpg GRAPHIC 29937
  Complete submission text file 0001827506-24-000108.txt   7856527

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT trml-20241210.xsd EX-101.SCH 1800
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT trml-20241210_lab.xml EX-101.LAB 23449
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT trml-20241210_pre.xml EX-101.PRE 13593
58 EXTRACTED XBRL INSTANCE DOCUMENT trml-20241210_htm.xml XML 2915
Mailing Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010
Business Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010 646-481-9832
Tourmaline Bio, Inc. (Filer) CIK: 0001827506 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40384 | Film No.: 241538543
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)